ORMDL3 and metabolic dysfunction-associated steatohepatitis: Taken together, these results suggest that overexpression of ORMDL3 in obese mice bestows sexual dimorphism of hepatic steatosis, hypercholesterolemia, and exacerbated fibrosis, leading to the early development of NASH characteristics.